Advertisement
Screener

DRAFTKINGS INC. (DKNG) Spending and interest coverage

DRAFTKINGS INC. (DKNG) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 5.20%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months5.20%Share-based compensation / revenue. Period ending 2026-06-30.

$323.53M ÷ $6.22B × 100 ≈ 5.20%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue6.22B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation323.53M USDShare-based Payment Arrangement, Noncash Expense
Operating income-182.46M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$6.22B$323.53M$-182.46M(m)(m)5.20%(m)(m)
2026-03-31(m)$6.29B$325.68M$36.36M(m)(m)5.18%(m)(m)
2025-12-31(m)$6.05B$339.31M$-15.82M(m)(m)5.60%(m)(m)
2025-09-30(m)$5.46B$346.08M$-306.76M(m)(m)6.34%(m)(m)
2025-06-30(m)$5.41B$361.16M$-333.46M(m)(m)6.68%(m)(m)
2025-03-31(m)$5.00B$366.68M$-516.49M(m)(m)7.33%(m)(m)
2024-12-31(m)$4.77B$381.37M$-609.00M(m)(m)8.00%(m)(m)
2024-09-30(m)(m)$384.82M$-513.63M(m)(m)(m)(m)(m)
2024-06-30(m)(m)$375.63M$-501.62M(m)(m)(m)(m)(m)
2024-03-31(m)(m)$374.60M$-538.28M$2.67M(m)(m)-201.38×Reported
2023-12-31(m)(m)$398.46M$-789.23M$2.68M(m)(m)-294.60×Reported
2023-09-30(m)(m)$415.11M$-977.64M(m)(m)(m)(m)(m)
2023-06-30(m)(m)$462.79M$-1.15B(m)(m)(m)(m)(m)
2023-03-31(m)(m)$509.12M$-1.39B(m)(m)(m)(m)(m)
2022-12-31(m)(m)$578.80M$-1.51B(m)(m)(m)(m)(m)
2022-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31(m)(m)$683.29M$-1.56B(m)(m)(m)(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)(m)$325.04M$-843.26M(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.